Elisa Hebb
Chief Tech/Sci/R&D Officer at ENDOLOGIX, INC.
Active connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
Matthew Thompson | M | 62 | 8 years | |
Nathaniel R. Bowditch | M | - |
Apneon, Inc.
Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | 18 years |
Lionel M. Nelson | M | - |
Apneon, Inc.
Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | 21 years |
Tim Brady | M | 43 | 9 years | |
Cindy Pinto | F | - | - | |
Richard Mott | M | 65 | 4 years | |
Elizabeth Rothwell | F | 55 | 2 years | |
Andrew ElBardissi | M | 42 | 4 years | |
Eric Lambert | M | - | 3 years | |
Christopher Leach | M | - | 4 years | |
Arif Iftekhar | M | - | 3 years | |
Genevieve Dunbar | F | - | 3 years | |
Sasha King | F | - | 2 years | |
James Mark Mattern | M | - |
Crux Biomedical, Inc.
Crux Biomedical, Inc. Medical SpecialtiesHealth Technology Crux Biomedical, Inc. develops and manufactures medical devices. The company was founded by Thomas Fogarty and Frank Arko in August 2004 and is headquartered in San Diego, CA. | - |
Gabriela Tomescu | F | - |
Apneon, Inc.
Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | 19 years |
David A. Dripchak | M | - | 9 years | |
Lucas Buchanan | M | 46 | 1 years | |
Roberta Hines | F | - |
Crux Biomedical, Inc.
Crux Biomedical, Inc. Medical SpecialtiesHealth Technology Crux Biomedical, Inc. develops and manufactures medical devices. The company was founded by Thomas Fogarty and Frank Arko in August 2004 and is headquartered in San Diego, CA. | - |
Murli Srinivasan | M | - |
Crux Biomedical, Inc.
Crux Biomedical, Inc. Medical SpecialtiesHealth Technology Crux Biomedical, Inc. develops and manufactures medical devices. The company was founded by Thomas Fogarty and Frank Arko in August 2004 and is headquartered in San Diego, CA. | - |
Eric Johnson | M | - |
Crux Biomedical, Inc.
Crux Biomedical, Inc. Medical SpecialtiesHealth Technology Crux Biomedical, Inc. develops and manufactures medical devices. The company was founded by Thomas Fogarty and Frank Arko in August 2004 and is headquartered in San Diego, CA. | - |
Andrew W. Kramer | M | - |
Apneon, Inc.
Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | 18 years |
Bryan B. Sendrowski | M | - | - | |
Avi Kometz | M | - | - | |
Nathan Every | M | - |
Apneon, Inc.
Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | - |
Sumner Esten Anderson | M | - | - | |
Marc-Henri Galletti | M | - |
Apneon, Inc.
Apneon, Inc. Medical SpecialtiesHealth Technology Founded in 2003 by Dr. Lionel Nelson and Eric Doelling, Apneon is dedicated to developing innovative solutions for treating obstructive sleep apnea (OSA) - the cessation of breathing during sleep. OSA is a serious and life-threatening condition that plagues millions of Americans and is most commonly recognized by excessive daytime sleepiness. Even with current treatments, sleep apnea is associated with significantly increased risk of stroke and death. Current treatment methods tend to be poorly tolerated, and/or of limited efficacy. Apneon is developing a unique and inventive approach intended to provide an effective treatment for OSA. | - |
Matt Poole | M | - | 4 years |
Connections Chart
Multi-company connection
Former connections
Name | Gender | Age | Linked companies | Collaboration |
---|---|---|---|---|
John Onopchenko | M | 66 | 15 years | |
Leslie Norwalk | F | 58 | 9 years | |
Vaseem Mahboob | M | 55 | 5 years | |
R. Huennekens | M | 59 | 13 years | |
Darin Lippoldt | M | 58 | 4 years | |
Ronald A. Matricaria | M | 81 | 10 years | |
Jeremy Hayden | M | 54 | 7 years | |
Kieran Gallahue | M | 60 | 8 years | |
Lesley H. Howe | M | 80 | 10 years | |
Roy Tanaka | M | 75 | 5 years | |
Joseph A. DeJohn | M | 63 | 13 years | |
Siddhartha Kadia | M | 54 | 2 years | |
Jane Kiernan | F | 63 | - | |
Thomas Wilder | M | 60 | 10 years | |
David Saul | M | - | - | |
John Dahldorf | M | 67 | 12 years | |
David M. Sheehan | M | 61 | 6 years | |
Alexis V. Lukianov | M | 68 | 8 years | |
Guido Neels | M | 75 | 9 years | |
Randy D. Lindholm | M | 68 |
Crux Biomedical, Inc.
Crux Biomedical, Inc. Medical SpecialtiesHealth Technology Crux Biomedical, Inc. develops and manufactures medical devices. The company was founded by Thomas Fogarty and Frank Arko in August 2004 and is headquartered in San Diego, CA. | - |
Gregory Waller | M | 74 | 17 years | |
Eric Topol | M | 69 | 3 years | |
Jeffry A. Fecho | M | 63 | 2 years | |
Reyna M. Fernandez | F | 57 | - | |
Mike Maszy | M | - | 2 years | |
John D. Zehren | M | - | 1 years | |
Jeffrey S. Brown | M | - | - | |
Meg Carr | F | - | 2 years | |
Jeff Stelk | M | - | 14 years | |
John Blake | M | 47 | 8 years | |
Heather Ace | F | 54 | 3 years | |
W. Stephens | M | 55 | 2 years | |
Michele Perrino | M | - | 8 years | |
Daniel Wolterman | M | 67 | 2 years | |
David M. Jennings | M | 69 | 6 years | |
Neil A. Hattangadi | M | 46 | 4 years | |
George Quinoy | M | 70 | 13 years | |
Taylor Harris | M | 48 | 3 years | |
Michael V. Chobotov | M | 63 | 5 years | |
Tim A. Benner | M | - | - |
Statistics
Country | Connections | % of total |
---|---|---|
United States | 67 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Elisa Hebb
- Personal Network